Cipta Sarana Medika Tbk. vs Fortune Mate Indonesia Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 21.14M 24h volume), while Fortune Mate Indonesia Tbk trades at Rp248 (market cap 1.61T, 27.4K 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 10× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (21.14M versus 27.4K). Which is the better fit depends on your goals.
| DKHH | FMII | |
|---|---|---|
Market Cap | 160.67B | 1.61T |
Volume | 21.14M | 27.4K |
Lot | 211.4K | 274 |
Turnover | 1.38B | 6.81M |
Average Price | 65.24 | 248.36 |
Value | 1.38B | 6.81M |
Indicative Equilibrium Price | 64 | 252 |
Indicative Equilibrium Volume | 1.35K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →